TWI317737B - Membrane penetrating peptides and uses thereof - Google Patents

Membrane penetrating peptides and uses thereof

Info

Publication number
TWI317737B
TWI317737B TW090120788A TW90120788A TWI317737B TW I317737 B TWI317737 B TW I317737B TW 090120788 A TW090120788 A TW 090120788A TW 90120788 A TW90120788 A TW 90120788A TW I317737 B TWI317737 B TW I317737B
Authority
TW
Taiwan
Prior art keywords
penetrating peptides
membrane penetrating
membrane
peptides
penetrating
Prior art date
Application number
TW090120788A
Other languages
English (en)
Inventor
Guo Yong
C Morse Clarence
Yao Zhengbin
A Keesler George Jr
Original Assignee
Aventis Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Holdings Inc filed Critical Aventis Holdings Inc
Application granted granted Critical
Publication of TWI317737B publication Critical patent/TWI317737B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW090120788A 2000-08-25 2001-08-24 Membrane penetrating peptides and uses thereof TWI317737B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22764700P 2000-08-25 2000-08-25
GBGB0103110.3A GB0103110D0 (en) 2000-08-25 2001-02-07 A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1

Publications (1)

Publication Number Publication Date
TWI317737B true TWI317737B (en) 2009-12-01

Family

ID=22853919

Family Applications (1)

Application Number Title Priority Date Filing Date
TW090120788A TWI317737B (en) 2000-08-25 2001-08-24 Membrane penetrating peptides and uses thereof

Country Status (10)

Country Link
US (2) US20030229202A1 (zh)
JP (1) JP4896356B2 (zh)
KR (1) KR100810927B1 (zh)
AR (1) AR033834A1 (zh)
BR (1) BRPI0113477B8 (zh)
DE (1) DE60133585T2 (zh)
GB (1) GB0103110D0 (zh)
IL (1) IL154589A (zh)
TW (1) TWI317737B (zh)
ZA (1) ZA200301476B (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128922B2 (en) * 1999-10-20 2012-03-06 Johns Hopkins University Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
KR20030062788A (ko) * 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 ｍｐｈ1-ｂｔｍ 및 이것을포함하는 생명공학제품
US20060008464A1 (en) * 2002-04-08 2006-01-12 Chaim Gilon Histone conjugates and uses thereof
WO2004098526A2 (en) 2003-05-05 2004-11-18 Johns Hopkins University Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2005000403A2 (en) * 2003-05-19 2005-01-06 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
JP2007505621A (ja) * 2004-04-13 2007-03-15 メドトロニック・ソファモア・ダネック 骨誘導タンパク質及びペプチドの細胞内送達
US8221740B2 (en) * 2005-09-26 2012-07-17 The Trustees Of Columbia University In The City Of New York Side population cells in cardiac repair
JP2010509181A (ja) * 2005-11-04 2010-03-25 フォーヒューマンテック・カンパニー・リミテッド 融合ポリペプチドを細胞へ輸送する方法
CN101490080A (zh) * 2006-07-24 2009-07-22 为人技术株式会社 用于缓解和治疗缺血性病症的药物组合物及其输送方法
KR100843634B1 (ko) * 2006-08-03 2008-07-03 연세대학교 산학협력단 세포막투과 전달 펩타이드 및 이를 포함하는 생물제제
US20080132450A1 (en) * 2006-08-29 2008-06-05 Forhumantech. Co., Ltd. Pharmaceutical composition for suppression of apoptosis and method for delivering the same
US7981446B2 (en) * 2007-11-26 2011-07-19 Forhumantech. Co., Ltd. Pharmaceutical compositions and methods for delivering nucleic acids into cells
US20100297758A1 (en) * 2008-01-25 2010-11-25 Toagosei Co., Ltd Artificial peptide and use thereof
WO2009105671A2 (en) * 2008-02-21 2009-08-27 Burnham Institute For Medical Research Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications
WO2010117079A1 (ja) 2009-04-10 2010-10-14 東亞合成株式会社 神経分化誘導ペプチド及びその利用
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
WO2011005540A1 (en) * 2009-06-22 2011-01-13 Burnham Institute For Medical Research Methods and compositions using peptides and proteins with c-terminal elements
JP5858284B2 (ja) * 2009-07-29 2016-02-10 東亞合成株式会社 キャリアペプチドフラグメントとその利用
WO2011013698A1 (ja) 2009-07-29 2011-02-03 東亞合成株式会社 キャリアペプチドフラグメント及びその利用
JP5858285B2 (ja) * 2009-07-29 2016-02-10 東亞合成株式会社 キャリアペプチドフラグメント及びその利用
WO2011052679A1 (ja) 2009-11-02 2011-05-05 東亞合成株式会社 細胞増殖促進ペプチド及びその利用
JP5808082B2 (ja) * 2010-04-30 2015-11-10 株式会社Adeka 細胞への水溶性高分子量物質の導入方法及び導入剤
JP6044032B2 (ja) * 2010-05-25 2016-12-14 国立大学法人 熊本大学 物質導入用プラズマ照射装置を用いた物質導入方法
EP2578224B1 (en) 2010-06-04 2017-11-22 Toagosei Co., Ltd. Cell growth-promoting peptide and use thereof
US9238796B2 (en) 2010-06-04 2016-01-19 Toagosei Co. Ltd. Cell growth-promoting peptide and use thereof
JP6202707B2 (ja) * 2011-10-13 2017-09-27 国立大学法人鳥取大学 新規細胞膜透過ペプチド
WO2013180011A1 (ja) 2012-05-28 2013-12-05 東亞合成株式会社 抗菌ペプチド及びその利用
US20140072961A1 (en) * 2012-07-11 2014-03-13 University of Nevada, Las Vegas Method of Genome Surgery with Paired, Permeant Endonuclease Excision
US9480727B2 (en) 2012-10-18 2016-11-01 Toagosei Co. Ltd. Synthetic peptide for inhibiting expression of type 2 TNF receptor and use thereof
JP2016504047A (ja) * 2013-01-18 2016-02-12 グリコトープ ゲーエムベーハー タンパク質発現を向上させるための融合ペプチド
WO2015089487A1 (en) 2013-12-12 2015-06-18 Life Technologies Corporation Membrane-penetrating peptides to enhance transfection and compositions and methods for using same
US10456475B2 (en) 2015-02-03 2019-10-29 Kennsaw State University Research and Service Foundation, Inc. Cell penetrating protein adaptor molecules and their application in research and medicine
JP6880526B2 (ja) 2015-02-27 2021-06-02 学校法人常翔学園 膜透過性ペプチドを側鎖に有する高分子化合物
CN107207627B (zh) 2015-02-27 2022-05-24 学校法人常翔学园 具有膜透过性肽链的多糖衍生物
US10435446B2 (en) 2015-06-03 2019-10-08 Kennesaw State University Research and Service Foundation Inc. Cell penetrating protein adaptor molecules and their application in research and medicine
US10654894B2 (en) 2016-02-03 2020-05-19 Keenesaw State University Research And Service Foundation, Inc. Methods for delivering cargo into a cell by using signal molecules as cell penetration agents
IL271587B2 (en) 2017-06-22 2024-05-01 Catalyst Biosciences Inc Modified membrane-type serine protease 1 polypeptides (MTSP-1) and methods of use
WO2019157089A1 (en) * 2018-02-06 2019-08-15 University Of Maryland, Baltimore Tlr9 inhibitors to suppress inflammatory response to pathogens
KR102386498B1 (ko) * 2018-12-27 2022-04-15 한양대학교 산학협력단 Crispr-cas를 기반으로 하는 유전자 교정용 조성물
US20220009968A1 (en) * 2018-12-27 2022-01-13 Industry-University Cooperation Foundation Hanyang University Crispr-cas-based composition for gene correction
US11613744B2 (en) 2018-12-28 2023-03-28 Vertex Pharmaceuticals Incorporated Modified urokinase-type plasminogen activator polypeptides and methods of use
JOP20210146A1 (ar) 2018-12-28 2023-01-30 Vertex Pharma بولي ببتيدات منشط بلازمينوجين من نوع يوروكيناز معدلة وطرق استخدامها
CN110441156A (zh) * 2019-07-20 2019-11-12 大连理工大学 一种基于土体稳定状态特性测量三轴试样膜嵌入量的方法
CN114716569B (zh) * 2022-04-13 2023-11-10 浙江大学 一种携带目标蛋白自主进入真核细胞的重组蛋白、重组表达载体和重组菌及应用
CN116120400A (zh) * 2022-12-20 2023-05-16 浙江大学杭州国际科创中心 一种细胞穿膜肽及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US6316003B1 (en) 1989-12-21 2001-11-13 Whitehead Institute For Biomedical Research Tat-derived transport polypeptides
US5674980A (en) 1989-12-21 1997-10-07 Biogen Inc Fusion protein comprising tat-derived transport moiety
US6197925B1 (en) * 1991-08-22 2001-03-06 Sara Lee Corporation NF-AT polypeptides and polynucleotides
US5843643A (en) * 1992-02-21 1998-12-01 Ratner; Paul L. Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid
US5766903A (en) 1995-08-23 1998-06-16 University Technology Corporation Circular RNA and uses thereof
US6235521B1 (en) * 1996-08-09 2001-05-22 Dnavec Research Phage bonded to a nuclear location signal
US5962415A (en) 1996-09-20 1999-10-05 Bristol-Myers Squibb Co. Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof
US5877282A (en) 1996-09-20 1999-03-02 Bristol-Myers Squibb Company Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof
US5929042A (en) 1997-03-03 1999-07-27 The Trustees Of Columbia University In The City Of New York Antisense compounds which prevent cell death and uses thereof
WO1998049325A1 (en) 1997-04-28 1998-11-05 Mcgill University Reporter fusion proteins, expression vectors and transfected cell lines thereof for the analysis of nuclear transport
FR2767323B1 (fr) 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6258774B1 (en) 1998-03-19 2001-07-10 University Of Medicine And Dentistry Of New Jersey Carrier for in vivo delivery of a therapeutic agent
SE9801055D0 (sv) * 1998-03-25 1998-03-25 Inst Of Molecul & Cell Biology Use of growth hormone binding protein (GHBP)
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
US6436628B1 (en) * 1998-06-19 2002-08-20 The Rockefeller University Methods of identifying an agent which modulates period and doubletime protein interaction
WO2000002950A1 (en) 1998-07-13 2000-01-20 Expression Genetics, Inc. Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
US6246558B1 (en) * 1998-08-24 2001-06-12 Leviton Manufacturing Company Circuit interrupting device with reverse wiring protection
FR2786397B1 (fr) 1998-11-30 2003-01-10 Synt Em Vecteurs peptidiques de substances a travers la barriere hematoencephalique pour etre utilises dans le diagnostic ou la therapie d'une affection du snc
FR2786398B1 (fr) 1998-11-30 2002-12-27 Synt Em Composition pharmaceutique anti-cancereuse et anti-chimioresistance comprenant un agent anticancereux et au moins un peptide
KR100722176B1 (ko) * 1999-06-08 2007-05-29 아벤티스 파마슈티칼스 인크. 일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
JP2003514564A (ja) 1999-11-24 2003-04-22 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法
JP3908425B2 (ja) * 1999-12-24 2007-04-25 アルパイン株式会社 ナビゲーション装置
MXPA02012198A (es) 2000-06-09 2004-08-19 Teni Boulikas Encapsulacion de polinucleotidos y drogas en liposomas objetivos.
JP3686961B2 (ja) * 2000-08-04 2005-08-24 シャープ株式会社 液晶表示装置及びそれを用いた電子機器
JP2002304088A (ja) * 2001-04-09 2002-10-18 Ricoh Co Ltd 画像形成装置
US20040002455A1 (en) * 2002-01-29 2004-01-01 Aventis Pasteur, Ltd. Targeted immunogens
US6877262B2 (en) * 2003-07-10 2005-04-12 Ronald Bianco Perpetual calendar
DE10341112A1 (de) * 2003-09-05 2005-03-31 Li-Li Yehhsu Behälter mit separaten Speicherkammern
MXPA06007574A (es) * 2003-12-31 2007-04-17 Sanofi Pasteur Inc Inmunogenos dirigidos.

Also Published As

Publication number Publication date
ZA200301476B (en) 2004-06-22
BR0113477A (pt) 2004-04-20
IL154589A (en) 2011-08-31
AR033834A1 (es) 2004-01-07
BRPI0113477B8 (pt) 2021-05-25
US20060100134A1 (en) 2006-05-11
US20030229202A1 (en) 2003-12-11
JP2004512275A (ja) 2004-04-22
JP4896356B2 (ja) 2012-03-14
GB0103110D0 (en) 2001-03-28
DE60133585D1 (de) 2008-05-21
US7754678B2 (en) 2010-07-13
KR20030034156A (ko) 2003-05-01
KR100810927B1 (ko) 2008-03-10
DE60133585T2 (de) 2009-06-04
BRPI0113477B1 (pt) 2019-10-22

Similar Documents

Publication Publication Date Title
TWI317737B (en) Membrane penetrating peptides and uses thereof
IL153970A0 (en) Promyostatin peptides and methods of using same
EP1342452A4 (en) TROCAR AND TROCAR SYSTEM
GB0014870D0 (en) Peptides
AU2001279075A1 (en) Water- and ion-conducting membranes and uses thereof
GB9806806D0 (en) Peptides and uses thereof
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
EP1370344A4 (en) POLYMER MEMBRANE AND THEIR USE
GB0004016D0 (en) Biological material and uses thereof
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
GB2367839B (en) Membrane and building construction
EP1343819A4 (en) HLA-A2.1 BINDING SPEPTIDES AND THEIR USE
GB0026134D0 (en) Peptides and their use
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
EP1337543A4 (en) STREPTAVIDINE-BINDING PEPTIDES AND USES THEREOF
GB0001825D0 (en) Peptides
IL153740A0 (en) Grf2-binding proteins and applications thereof
AU2001250585A1 (en) Insecticidal peptides and methods for using same
GB0013185D0 (en) Films and uses thereof
AU5368201A (en) Mre11 orthologue and uses thereof
GB0007263D0 (en) Peptides
SG2012018057A (en) Replikin peptides and uses thereof
GB0018148D0 (en) Peptides and their use

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent